Clinical Trials Directory

Trials / Completed

CompletedNCT03445351

Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS

Effect of Exercise on Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
JULIANY DE SOUZA ARAUJO · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Aim: Evaluate the influence of exercise, in different times, on quality of life, sleep and clinical parameters in people living with HIV/AIDS (PLHA). Methods: Intervention study, prospective.

Detailed description

Aim: Evaluate the influence of exercise, in different times, on quality of life, sleep and clinical parameters in people living with HIV/AIDS (PLHA). Methods: Intervention study, prospective, a cohort with 17 PLHA participants of the exercise program, higher than 18 years, under antiretroviral therapy with CD4+ ≥ 350/mm3. Research Ethical Committee of the institution approved the study and the participants sign the informed consent and informed. All subjects underwent an exercise program in conformity to American College of Sports Medicine, 3 times per week during 40 minutes. Were evaluated the quality of life (QoL) with the Quality of Life - HAT - QoL and the sleep quality (SQ) with the Pittsburg questionnaire. The subjects were evaluated before the start of exercise program and in three times: short-term (2 to 4 months), medium-term (between 5 and 17 months) and long-term (between 18 to 25 months).

Conditions

Interventions

TypeNameDescription
OTHERAerobic, resistance and concorrent.All protocols followed the American College of Sports Medicine (ACSM) guidelines , with frequency of three times per week, duration between 40-50 minutes, low to high intensity, modified according to the physical needs of each participant, respecting the physical training principles.

Timeline

Start date
2013-01-20
Primary completion
2015-04-22
Completion
2016-09-13
First posted
2018-02-26
Last updated
2018-02-26

Source: ClinicalTrials.gov record NCT03445351. Inclusion in this directory is not an endorsement.